Illness	Number of cases
Depressive episode - Major depressive disorder single episode moderate (F32.1)	98
Reaction to severe stress and adjustment disorders (F43.2)	22
Hyperkinetic disorders - Attention-deficit hyperactivity disorder predominantly hyperactive type (F90.1)	19
Pervasive developmental disorders - Autistic disorder (F84.0)	13
Mixed disorders of conduct and emotions (F92.8)	13
Mixed disorders of conduct and emotions (F92.0)	12
Reaction to severe stress and adjustment disorders (F43.1)	11
Hyperkinetic disorders - Attention-deficit hyperactivity disorder predominantly inattentive type (F90.0)	7
Schizophrenia - Paranoid schizophrenia (F20.0)	6
Recurrent depressive disorder - Major depressive disorder recurrent moderate (F33.1)	4

Top 10 treatments

Treatment	Number
(9-696.10)	354
Regular treatment for mental and psychosomatic disorders and behavioural disorders in children and adolescents (9-656)	261
(9-696.51)	205
(9-696.40)	190
Intensive psychiatric-psychosomatic treatment for mental and psychosomatic disorders and behavioral disorders in children and adolescents (9-672)	184
(9-696.32)	143
(9-696.54)	142
(9-696.53)	124
(9-696.11)	115
(9-696.20)	109

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 3000

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	2
Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	2

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
12	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
5	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
5	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility